195 related articles for article (PubMed ID: 24225756)
21. p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma.
Bishop JA; Teruya-Feldstein J; Westra WH; Pelosi G; Travis WD; Rekhtman N
Mod Pathol; 2012 Mar; 25(3):405-15. PubMed ID: 22056955
[TBL] [Abstract][Full Text] [Related]
22. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity.
Uchida K; Ross H; Lotan T; Pignon JC; Signoretti S; Epstein JI; Illei PB
Hum Pathol; 2015 Mar; 46(3):384-9. PubMed ID: 25548110
[TBL] [Abstract][Full Text] [Related]
23. Pan-p63 but not ΔNp63 (p40) expression in undifferentiated carcinoma of the pancreas.
Liszka Ł
Pol J Pathol; 2020; 71(2):155-172. PubMed ID: 32729306
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive Analysis of PAX8 Expression in Epithelial Malignancies of the Uterine Cervix.
Wong S; Hong W; Hui P; Buza N
Int J Gynecol Pathol; 2017 Mar; 36(2):101-106. PubMed ID: 27362905
[TBL] [Abstract][Full Text] [Related]
25. Head-to-Head Comparison of p63 and p40 in Non-Neuroendocrine Carcinomas of the Tubal Gut.
Bakhshwin AM; Gordon IO; Brown KB; Liu X; Allende DS
Int J Surg Pathol; 2020 Dec; 28(8):835-843. PubMed ID: 32466705
[TBL] [Abstract][Full Text] [Related]
26. PAX2 and PAX8: useful markers for metastatic effusions.
Waters L; Crumley S; Truong L; Mody D; Coffey D
Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
[TBL] [Abstract][Full Text] [Related]
27. Differentiating Small Cell Carcinoma From Squamous Cell Carcinoma in Cytologic Specimens: A Head-to-Head Comparison of p40 and p63 Using Cell Block Immunocytochemistry.
Gailey MP; Bellizzi AM; Jensen CS
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):11-5. PubMed ID: 25906121
[TBL] [Abstract][Full Text] [Related]
28. CD138 Expression Is Observed in the Urothelial Epithelium and in Various Urothelial Carcinomas, and Cannot Be Evidence for Plasmacytoid Urothelial Carcinoma.
Goto K
Int J Surg Pathol; 2016 Oct; 24(7):614-9. PubMed ID: 27305940
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of GATA-3 in urothelial carcinoma variants.
Liang Y; Heitzman J; Kamat AM; Dinney CP; Czerniak B; Guo CC
Hum Pathol; 2014 Jul; 45(7):1466-72. PubMed ID: 24745616
[TBL] [Abstract][Full Text] [Related]
30. Utility of p40 in the Differential Diagnosis of Small Round Blue Cell Tumors of the Sinonasal Tract.
Tilson MP; Bishop JA
Head Neck Pathol; 2014 Jun; 8(2):141-5. PubMed ID: 24114197
[TBL] [Abstract][Full Text] [Related]
31. p40: a p63 isoform useful for lung cancer diagnosis - a review of the physiological and pathological role of p63.
Nobre AR; Albergaria A; Schmitt F
Acta Cytol; 2013; 57(1):1-8. PubMed ID: 23221041
[TBL] [Abstract][Full Text] [Related]
32. Expression of PAX8 in nephrogenic adenoma and clear cell adenocarcinoma of the lower urinary tract: evidence of related histogenesis?
Tong GX; Weeden EM; Hamele-Bena D; Huan Y; Unger P; Memeo L; O'Toole K
Am J Surg Pathol; 2008 Sep; 32(9):1380-7. PubMed ID: 18670350
[TBL] [Abstract][Full Text] [Related]
33. PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody.
Hu Y; Hartmann A; Stoehr C; Zhang S; Wang M; Tacha D; Montironi R; Lopez-Beltran A; Cheng L
J Clin Pathol; 2012 Mar; 65(3):254-6. PubMed ID: 22135028
[TBL] [Abstract][Full Text] [Related]
34. Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues.
Lu J; Zhao M; Wu C; Chu C; Zhang CZ; Cao Y
Diagn Pathol; 2022 Jan; 17(1):10. PubMed ID: 35027056
[TBL] [Abstract][Full Text] [Related]
35. Pax8: a marker for carcinoma of Müllerian origin in serous effusions.
Tong GX; Devaraj K; Hamele-Bena D; Yu WM; Turk A; Chen X; Wright JD; Greenebaum E
Diagn Cytopathol; 2011 Aug; 39(8):567-74. PubMed ID: 20607683
[TBL] [Abstract][Full Text] [Related]
36. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
Nonaka D; Chiriboga L; Soslow RA
Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
[TBL] [Abstract][Full Text] [Related]
37. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung.
Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J
Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical profile of the penile urethra and differential expression of GATA3 in urothelial versus squamous cell carcinomas of the penile urethra.
Chaux A; Han JS; Lee S; Gonzalez-Roibon N; Sharma R; Burnett AL; Cubilla AL; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2760-7. PubMed ID: 24134931
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical markers for the differential diagnosis of nephrogenic adenomas.
Quinones W; Ziober A; Yao Y; Bing Z
Ann Diagn Pathol; 2013 Feb; 17(1):41-4. PubMed ID: 22672805
[TBL] [Abstract][Full Text] [Related]
40. Statistical analysis of cytologic features useful in separation of metastatic urothelial carcinoma from other metastatic epithelial malignancies.
Layfield LJ; Jones C; Hirschowitz S
Diagn Cytopathol; 2003 Dec; 29(6):334-8. PubMed ID: 14648790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
